RavenQuest BioMed Inc (CNSX:RQB) Client Bonify Achieves Landmark Health Canada Licence Reinstation

Midas Letter

English - October 23, 2019 21:15 - 12.9 MB - ★★★★ - 7 ratings
Investing Business News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Halo Labs Inc (NEO:HALO) Rising Vape Sales and Safety Testing During Current Vape Climate

Next Episode: Harvest Health & Recreation (CNSX:HARV) Aim on Becoming the Largest Vertically Integrated MSO

RavenQuest BioMed Inc (CNSX:RQB) (OTCMKTS:RVVQF) (FRA:1IT) CEO George Robinson join Midas Letter to discuss its client company’s landmark success. RavenQuest provides comprehensive management services including operational direction and oversight to Bonify’s 320,000 square foot cannabis production facility located in Winnipeg, Manitoba. For the first time in the history of Canadian legal cannabis sales, Bonify has had its Health Canada license suspension lifted and sales license fully reinstated. RavenQuest provided the necessary direction and corrective action to restore confidence with Health Canada and ultimately fully restore Bonify’s sales license. RavenQuest has a history as a leading consultant in the Canadian cannabis space improving and streamlining production operations.

Original article: RavenQuest BioMed Inc (CNSX:RQB) Client Bonify Achieves Landmark Health Canada Licence Reinstation